Suppression of E6 Oncogene Induces Apoptosis in CaSki Cervical Cancer Cells.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 Oct 2023
Historique:
received: 09 02 2023
medline: 30 10 2023
pubmed: 29 10 2023
entrez: 29 10 2023
Statut: epublish

Résumé

The most important casuse of cervical cancer incidence and high mortality rate is infection to the human papillomavirus (HPV). The aim of the present study was to investigate the effect of silencing HPV E6 oncogene on cervical cancer cells using specific siRNAs. CaSki cervical cancer cells, carrying E6 gene, were cultured and then transfected with E6 targeting siRNAs. The cell viability through suppression of E6 expression was explored using MTT assay. Besides, apoptosis induction was investigated by means of flow cytometry using Annexin / PI staining. The changes in the expression of target genes were examined via  Real-Time PCR. E6 gene silencing caused a significant decrease in the survival rate of CaSki cells through remarkable enhancement of apoptosis induction. Moreover, E6 suppression led to significant upregulation of P53, Bax, Caspase-3, and Caspase-9 mRNA expression while downregulated Bcl-2 expression. Interestingly, it was found that suppression of E6 expression could lead to upregulation of  E5 and E7 expression as a compensatory mechanism for E6 deactivation. According to the results of this study, suppression of E6 expression using specific siRNAs could be considered as a therapeutic approach for cervical cancer.

Identifiants

pubmed: 37898842
doi: 10.31557/APJCP.2023.24.10.3389
pii:
doi:

Substances chimiques

Oncogene Proteins, Viral 0
Repressor Proteins 0
RNA, Small Interfering 0
Papillomavirus E7 Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3389-3395

Auteurs

Farnaz Rasi (F)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Habib Zarredar (H)

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Amini (M)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Habib Onsori (H)

Department of Biology Sciences, Marand Branch, Islamic Azad University, Marand, Iran.

Kianoosh Dadashzadeh (K)

Department of Laboratory Sciences, Marand Branch, Islamic Azad University, Marand, Iran.

Majid Khanmohammadi (M)

Department of Laboratory Sciences, Marand Branch, Islamic Azad University, Marand, Iran.

Leila Vahedi (L)

Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Ahad Mokhtarzadeh (A)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Behzad Baradaran (B)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Hossein Bannazadeh Baghi (H)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH